The enzyme, O-GlcNAc transferase (OGT) that modifies nucleocytoplasmic proteins with O-GlcNAc has recently been shown to be part of the co-repressor complex turning off the transcription of genes. OGT associates with mSinSA and, therefore, is involved with genes that bind nuclear hormone receptors when the hormones, like estrogen, are not present. By modifying transcription activators, OGT cooperates with histone deacetylase to shut off transcription at sites where its scaffold, mSin3A, is present. Bound to OGT in a saturable fashion is NCOAT (nuclear cytoplasmic O-GlcNAcase and acetyltransferase), a bifunctional enzyme with O-GlcNAcase and histone acetyltransferase activities. NCOAT, by residing in co-repression complexes, allows the gene to be turned on again when hormone becomes present by reversing the actions of OGT and histone deacetylase. An NCOAT peptide that interacts with OGT, but has no enzymatic activities, blocks the ability of estrogen to induce estrogen-dependent genes or mammary development in transgenic mice. Thus, NCOAT is downstream of hormone and requires activation to reverse the actions of histone deacetylase and OGT.
The aims of this project are as follows: 1. Further characterize transgene mice to determine the role of NCOAT in mammary development and other estrogen actions in the mammary gland. 2. Find where and how NCOAT is modified to activate it and what enzymes are involved. 3. Use the OGT interaction of NCOAT to design peptide therapy for breast cancer. This translational therapy will be developed to treat human breast cancer whose growth has become hormone-independent. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK043652-14A1
Application #
7030502
Study Section
Drug Discovery and Molecular Pharmacology Study Section (DMP)
Program Officer
Malozowski, Saul N
Project Start
1991-06-01
Project End
2010-11-30
Budget Start
2006-04-01
Budget End
2007-03-31
Support Year
14
Fiscal Year
2006
Total Cost
$298,275
Indirect Cost
Name
University of Alabama Birmingham
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Wu, Jing; Bowe, Damon B; Sadlonova, Andrea et al. (2014) O-GlcNAc transferase is critical for transducin-like enhancer of split (TLE)-mediated repression of canonical Wnt signaling. J Biol Chem 289:12168-76
Huang, Ping; Ho, Shiuh-Rong; Wang, Kai et al. (2011) Muscle-specific overexpression of NCOATGK, splice variant of O-GlcNAcase, induces skeletal muscle atrophy. Am J Physiol Cell Physiol 300:C456-65
Ho, Shiuh-Rong; Wang, Kai; Whisenhunt, Thomas R et al. (2010) O-GlcNAcylation enhances FOXO4 transcriptional regulation in response to stress. FEBS Lett 584:49-54
Wang, Kai; Ho, Shiuh-Rong; Mao, Weiming et al. (2009) Increased O-GlcNAc causes disrupted lens fiber cell differentiation and cataracts. Biochem Biophys Res Commun 387:70-6
Bowe, Damon B; Sadlonova, Andrea; Toleman, Clifford A et al. (2006) O-GlcNAc integrates the proteasome and transcriptome to regulate nuclear hormone receptors. Mol Cell Biol 26:8539-50
Whisenhunt, Thomas R; Yang, Xiaoyong; Bowe, Damon B et al. (2006) Disrupting the enzyme complex regulating O-GlcNAcylation blocks signaling and development. Glycobiology 16:551-63
Roh, Meejeon; Paterson, Andrew J; Liu, Kan et al. (2005) Proteolytic processing of TGFalpha redirects its mitogenic activity: the membrane-anchored form is autocrine, the secreted form is paracrine. Biochim Biophys Acta 1743:231-42
Roh, M; Paterson, A J; Asa, S L et al. (2001) Stage-sensitive blockade of pituitary somatomammotrope development by targeted expression of a dominant negative epidermal growth factor receptor in transgenic mice. Mol Endocrinol 15:600-13
Xie, W; Chow, L T; Paterson, A J et al. (1999) Conditional expression of the ErbB2 oncogene elicits reversible hyperplasia in stratified epithelia and up-regulation of TGFalpha expression in transgenic mice. Oncogene 18:3593-607
Xie, W; Wu, X; Chow, L T et al. (1998) Targeted expression of activated erbB-2 to the epidermis of transgenic mice elicits striking developmental abnormalities in the epidermis and hair follicles. Cell Growth Differ 9:313-25

Showing the most recent 10 out of 29 publications